In this study, we provided preclinical evidence that silenced TRPM7 expression significantly suppressed the metastatic trait of HNSCC cells, where the migration and invasion abilities of HNSCC cells were reduced and was associated with a decreased vimentin/E-cadherin ratio (Figure 2). The gene discussed is TRPM7; the disease is head and neck squamous cell carcinoma.